Jan 31, 2023 | Covid-19, News
In a new study, a team of University of Missouri researchers made an unexpected discovery: people experiencing long-lasting effects from COVID-19—known as “long COVID” or post-COVID conditions—are susceptible to developing only seven health symptoms for up to a year... 
Jan 31, 2023 | Covid-19, News
The Food and Drug Administration (FDA) vaccine advisory group today recommended streamlining COVID-19 vaccine campaigns by offering just the newer bivalent (two-strain) versions of the vaccine for both primary and booster series. The measure, which passed unanimously,... 
Jan 24, 2023 | Covid-19, News
In a document posted ahead of an advisory group meeting on Jan 26, the US Food and Drug Administration (FDA) today spelled out a proposal for annual COVID-19 vaccine shots for the majority of people and a system for updating the vaccines that mirrors that for flu... 
Jan 17, 2023 | Covid-19, News
Creative work featuring 3D renditions of three dangerous respiratory viruses: RSV (left), influenza (center), and SARS-CoV-2 (right). Note: Not to scale. CREDIT: NIAID Vaccines that provide long-lasting protection against influenza, coronaviruses and respiratory... 
Jan 10, 2023 | Covid-19, News
The National Institutes of Health has awarded eight research grants to refine new technologies for early diagnosis of severe illnesses resulting from SARS-CoV-2 infection in children. The new awards follow grants issued in 2020 to foster methods for diagnosing... 
Jan 10, 2023 | Covid-19, News
IBIS A) Neuron of the cerebral cortex infected with the SARS-CoV-2 coronavirus (viral particles in green). B and C) In B, cortical neurons infected by SARS-CoV-2 (in brown) and, in C, absence of infection in the same brain region of mice vaccinated with MVA-CoV2-S....
